Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study.
Rene Lindholm CordtzJohan AsklingBénédicte DelcoigneKarin E SmedbyEva BaecklundChristine BallegaardPia IsomäkiKalle AaltonenBjorn GudbjornssonThorvardur Jon LoveSella Aarrestad ProvanBrigitte MichelsenJoseph SextonLene DreyerKarin HellgrenPublished in: RMD open (2022)
Treatment with TNFi in patients with PsA was not associated with an increased incidence of haematological malignancies. Conversely, a moderately increased underlying risk was seen in patients with PsA compared with the general population.